Are compounds that might be seen in a clinical trial drawn from the same distribution as compounds that a lab chemist might accidentally taste? Is it weird that

Are compounds that might be seen in a clinical trial drawn from the same distribution as compounds that a lab chemist might accidentally taste? Is it weird that there's no overlap of a compound that is both very sweet and medically active?